DAIC

JUNE 12, 2024

and an investigator in the VIVID study , which contributed to the device’s FDA approval – successfully used the Duo Venous Stent System for the first time outside of a clinical trial. It is the third most common cardiovascular disease [2]. For long lesions, Duo Extend smoothly overlaps with the Duo Hybrid to extend therapy.

Stent 105

Stent Stents Anatomy Ultrasound 105

American College of Cardiology

FEBRUARY 1, 2025

In a retrospective study of older patients (≥65 years) with cardiovascular disease who were admitted to a cardiology service, the prevalence of polypharmacy (five or more medications) was 95% and 69% for hyper-polypharmacy (≥10 medications), far exceeding that observed in the general population; 77.5% 2021;374:n1493.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease CMS Hospital 40

Open Heart

JUNE 9, 2023

All the patients were observed during their hospital stay for postprocedure in-hospital morbidity (pump failure, contrast-induced nephropathy, major bleeding, cerebrovascular accident/stroke, access site complications or stent thrombosis) and mortality. The mean BMI was 27.48±4.93

Obesity 40

Obesity BMI Hospital Thrombosis 40

Cardiology Update

APRIL 9, 2024

Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). The primary non-inferiority endpoint was MACCE (a composite of cardiac death, MI, ischaemic stroke, stent thrombosis, or target vessel revascularisation).

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52